Flora Growth Corp. Announces Update on Sale of Colombian Assets; Expects Asset Sale to Contribute to Anticipated Annual Savings of US$6.1 million
July 25, 2023 MJ Shareholders
Ryan Allway
July 25th, 2023
Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, today provided an update with respect to the purchase and sale agreement for the sale of its Colombian related subsidiaries and assets to a private company in consideration for C$0.8 million, entered into on July 5, 2023. The sale relates to all of Flora’s operations in Colombia, including its interest in (i) its 361-acre Cosechemos farm located in Giron, Colombia and its related processing facilities and inventory and (ii) all other assets relating to Flora Lab 2, Flora Lab 4 and Flora’s Colombian food and beverage and consumer products business (collectively, the “Colombian Assets”). The sale is expected to close by July 31, 2023. The Company intends to maintain a presence in Latin America through Just Brands’ distribution relationships.
“The divestiture of our Colombian Assets is part of our plan to concentrate on core business divisions. This being a prominent lifestyle brand in the United States and a player in international pharmaceutical distribution focused on therapeutics, starting with medical cannabis,” said Clifford Starke, Flora’s Chief Executive Officer.
“We have made several strategic changes to cut costs and streamline operations. These changes are projected to deliver annual cost reductions amounting to US$6.1 million in cumulative annual savings when taken together with the US$3.4 million in savings from the divestiture of the Colombian Assets,” said Dany Vaiman, Flora’s Chief Financial Officer.
Flora’s Business Outlook
The Company’s 2023 revenue guidance issued previously included certain estimates relating to the Colombian Assets. Management believes such guidance should no longer be relied upon and is in the process of reevaluating such guidance. The Company anticipates providing updated 2023 revenue guidance at the appropriate time.
Executive Change
Matthew Cohen, General Counsel, has resigned from the Company for personal reasons.
About Flora Growth Corp.
Flora Growth Corp. is a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries. In the United States, Flora’s lifestyle business has established a robust presence across all 50 states, providing us with a solid foundation. Furthermore, we believe we possess substantial potential for international expansion. Based in Germany, we have successfully developed a strong distribution network delivering lifestyle and wellness products to 28 countries. For more information, kindly visit www.floragrowth.com or follow @floragrowthcorp on social media.
**Use Promo Code FLGC10 to Earn 10% Off Your Next Purchase**
https://www.phatebo.de/home-en
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
